Amanote Research
Register
Sign In
Soluble Thrombomodulin Concentration Is Raised in Scleroderma Associated Pulmonary Hypertension
Annals of the Rheumatic Diseases
- United Kingdom
doi 10.1136/ard.59.2.132
Full Text
Open PDF
Abstract
Available in
full text
Categories
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Date
February 1, 2000
Authors
R. J Stratton
Publisher
BMJ
Related search
Scleroderma Associated Pulmonary Hypertension
Advances in Pulmonary Hypertension
Pulmonary Arterial Hypertension Associated With Scleroderma
Advances in Pulmonary Hypertension
Scleroderma-Associated Pulmonary Hypertension: Who's at Risk and Why
Advances in Pulmonary Hypertension
Ambrisentan and Tadalafil Up-Front Combination Therapy in Scleroderma-Associated Pulmonary Arterial Hypertension
American Journal of Respiratory and Critical Care Medicine
Pulmonary
Critical Care
Respiratory Medicine
Intensive Care Medicine
Borderline Pulmonary Pressures in Scleroderma - A ‘Pre-Pulmonary Arterial Hypertension’ Condition?
Arthritis Research and Therapy
Rheumatology
Allergy
Immunology
Telangiectases in Scleroderma: A Potential Clinical Marker of Pulmonary Arterial Hypertension
Journal of Rheumatology
Rheumatology
Allergy
Immunology
Are Anti-Ro52 Antibodies Associated With Pulmonary Involvement in Scleroderma?
Journal of Pulmonary & Respiratory Medicine
Pulmonary Hypertension Associated With COPD
International Journal of COPD
Environmental
Public Health
Health Policy
Medicine
Pulmonary
Respiratory Medicine
Occupational Health
Pulmonary Hypertension Associated With Sarcoidosis
Advances in Pulmonary Hypertension